Cargando…
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve, several variants of concern (VOCs) have arisen which are defined by multiple mutations in their spike proteins. These VOCs have shown variable escape from antibody responses and have been shown to trigger qualitativ...
Autores principales: | Moyo-Gwete, Thandeka, Madzivhandila, Mashudu, Mkhize, Nonhlanhla N., Kgagudi, Prudence, Ayres, Frances, Lambson, Bronwen E., Manamela, Nelia P., Richardson, Simone I., Makhado, Zanele, van der Mescht, Mieke A., de Beer, Zelda, de Villiers, Talita Roma, Burgers, Wendy A., Ntusi, Ntobeko A. B., Rossouw, Theresa, Ueckermann, Veronica, Boswell, Michael T., Moore, Penny L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364786/ https://www.ncbi.nlm.nih.gov/pubmed/35867572 http://dx.doi.org/10.1128/jvi.00558-22 |
Ejemplares similares
-
Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351)
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2021) -
SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2021) -
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination
por: Motsoeneng, Boitumelo M., et al.
Publicado: (2023) -
Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2022) -
Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant
por: Richardson, Simone I., et al.
Publicado: (2022)